Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIIi concentrate
Kessler, C.; Lusher, J.; Pierce, G.F.; Pierce, B.; Koerper, M.A.; Dickinson, J.C.
Lancet 346(8985): 1297-1298
1995
ISSN/ISBN: 0140-6736 PMID: 7475738 Document Number: 446131
Document emailed within 1 workday
Related Documents
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830Mannucci, P.M.; Zanetti, A.R.; Colombo, M.; Chistolini, A.; De Biasi, R.; Musso, R.; Tamponi, G. 1990: Antibody to hepatitis C virus after a vapour-heated factor VIIi concentrate. the Study Group of the Fondazione dell'Emofilia Thrombosis and Haemostasis 64(2): 232-234
Andes, W.A. 1983: Factor VIIi concentrate--hepatitis JAMA 249(17): 2331
Levine, P.H. 1988: Human factor VIII:C purified using monoclonal antibody to von Willebrand factor Seminars in Hematology 25(2 Suppl 1: 1-2
Smit Sibinga, C.T.; Daenen, S.M.; van Imhoff, G.W.; Maas, A.; Das, P.C. 1984: Heparin small pool high yield purified factor VIII: in vivo recovery and half-life of routinely produced freeze-dried concentrate Thrombosis and Haemostasis 51(1): 12-15
Sabin, C.; Pasi, J.; Phillips, A.; Elford, J.; Janossy, G.; Lee, C. 1994: CD4+ counts before and after switching to monoclonal high-purity factor VIIi concentrate in HIV-infected haemophilic patients Thrombosis and Haemostasis 72(2): 214-217
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Kasper, C.K.; Kim, H.C.; Gomperts, E.D.; Smith, K.J.; Salzman, P.M.; Tipping, D.; Miller, R.; Montgomery, R.M. 1991: In vivo recovery and survival of monoclonal-antibody-purified factor VIII concentrates Thrombosis and Haemostasis 66(6): 730-733
Teitel, J.M.; Lau, H.K.; Garvey, M.B. 2002: Discrepancies in measured factor VIIi activity in patients treated with factor VIIi concentrate of human or porcine origin Thrombosis and Haemostasis 88(1): 159-160
Brettler, D.B.; Forsberg, A.D.; Levine, P.H.; Aledort, L.M.; Hilgartner, M.W.; Kasper, C.K.; Lusher, J.M.; McMillan, C.; Roberts, H. 1989: The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience Archives of Internal Medicine 149(6): 1381-1385
Allersma, D.P.; Smid, W.M.; van der Does, J.A.; van der Meer, J.; Briët, E. 1996: Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate Thrombosis and Haemostasis 75(2): 261-266
Arrighi, S.; Rossi, R.; Borri, M.G.; Lesnikov, V.; Lesnikova, M.; Franco, E.; Divizia, M.; De Santis, M.E.; Bucci, E. 1995: "In vitro" and in animal model studies on a double virus-inactivated factor VIII concentrate Thrombosis and Haemostasis 74(3): 868-873
Canales Albendea, M.A.; Villar Camacho, A.; Chamarro Merino, G.; Magallón Martínez, M. 1998: Ultrapure factor VIIi concentrate with double virus inactivation: study of pharmacokinetics in von Willebrand's disease patients Sangre 43(1): 93-94
Kessler, C.M.; Ludlam, C.A. 1993: The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group Seminars in Hematology 30(2 Suppl. 1): 22-27
Davis, H.M.; Brown, S.K.; Nash, D.W.; Pennetti, A.M.; Salzman, P.M.; Schreiber, A.B.; Haimovich, J. 1990: Lack of immune response to mouse IgG in hemophilia a patients treated chronically with Monoclate, a monoclonal antibody affinity purified factor VIIi preparation Thrombosis and Haemostasis 63(3): 386-391
Huang, X.; Cao, Y.; Tan, S. 2001: Horizontal transmission of live attenuated hepatitis a vaccine virus Zhonghua Yi Xue Za Zhi 81(8): 465-467
Rouzioux, C.; Chamaret, S.; Montagnier, L.; Carnelli, V.; Rolland, G.; Mannucci, P.M. 1985: Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated Factor VIIi concentrate Lancet 1(8423): 271-272
Nesic, Z.; Delic, D.; Prostran, M.; Vuckovic, S.; Stojanovic, R. 2002: Hepatitis G virus infection in individuals at high risk of transmission of viral hepatitis International Journal of Antimicrobial Agents 19(Suppl 1): S39
Simonetti, C.; Casillas, G.; Farías, C.; De los Santos, J.C. 1981: A new human factor VIIi concentrate. Preparation and clinical use Medicina 41 Suppl: 249-252
Allain, J.P.; Steinbuch, M.; Meunier, L.; Muller, J.Y.; Soulier, J.P. 1976: Substitutive treatment of hemopjolia a using a new factor VIIi concentrate La Nouvelle Presse Medicale 5(16): 1047-1050